- ISIN
- US04537V1052
- Issuer
- Aspiriant
- Inception Date
- Apr 3, 2013
- Category
- Global Equities
- Min. Investment
- $0
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Large-Cap
- Asset Class Style
- Blend
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
RMEAX Performance Chart
Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) is up 6.4% since the beginning of the year. RMEAX is currently trading at $17 per share. Investors who bought $1,000 worth of RMEAX shares 5 years ago would now be looking at an investment worth $1,426.
Loading charts...
Returns By Period
Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) has returned 6.39% so far this year and 19.27% over the past 12 months. Over the last ten years, RMEAX has returned 8.38% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Aspiriant Risk-Managed Equity Allocation Fund
- 1D
- 0.82%
- 1M
- 0.87%
- YTD
- 6.39%
- 6M
- 6.66%
- 1Y
- 19.27%
- 3Y*
- 12.22%
- 5Y*
- 7.35%
- 10Y*
- 8.38%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
RMEAX Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 2014, RMEAX's average daily return is +0.03%, while the average monthly return is +0.62%. At this rate, an investment would double in approximately 9.3 years.
Historically, 62% of months were positive and 38% were negative. The best month was Apr 2026 with a return of +7.1%, while the worst month was Mar 2020 at -11.4%. The longest winning streak lasted 14 consecutive months, and the longest losing streak was 4 months.
On a daily basis, RMEAX closed higher 51% of trading days. The best single day was Apr 9, 2025 with a return of +5.8%, while the worst single day was Mar 12, 2020 at -7.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.15% | 0.48% | -5.87% | 7.12% | 3.09% | -0.29% | 6.39% | ||||||
| 2025 | 3.69% | 0.37% | -2.42% | -0.57% | 3.46% | 3.47% | -0.72% | 2.77% | 2.40% | 0.97% | 2.10% | 1.08% | 17.69% |
| 2024 | 1.86% | 3.32% | 2.16% | -2.12% | 2.75% | 2.42% | 1.31% | 2.76% | 1.55% | -2.12% | 2.41% | -9.22% | 6.55% |
| 2023 | 4.33% | -2.99% | 2.70% | 2.56% | -0.86% | 3.96% | 2.42% | -1.55% | -2.54% | -1.06% | 5.98% | 2.72% | 16.31% |
| 2022 | -3.21% | -3.78% | 0.48% | -4.53% | -0.07% | -4.82% | 3.18% | -3.15% | -7.27% | 5.22% | 6.67% | -2.30% | -13.67% |
| 2021 | -0.50% | 1.01% | 2.94% | 3.69% | 1.88% | -0.07% | 1.12% | 2.02% | -3.96% | 3.79% | -2.24% | 4.54% | 14.78% |
Benchmark Metrics
Aspiriant Risk-Managed Equity Allocation Fund has an annualized alpha of 0.08%, beta of 0.58, and R2 of 0.74 versus S&P 500 Index. Calculated based on daily prices since January 02, 2014.
- This fund participated in 78.37% of S&P 500 Index downside but only 64.12% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.58 indicates this fund moves significantly less than S&P 500 Index - a genuinely defensive profile with reduced participation in both market rallies and downturns.
- Alpha
- 0.08%
- Beta
- 0.58
- R²
- 0.74
- Upside Capture
- 64.12%
- Downside Capture
- 78.37%
Expense Ratio
RMEAX has an expense ratio of 0.28%, placing it in the medium range.
Return for Risk
Risk / Return Rank
RMEAX ranks 45 for risk / return — on par with similar mutual funds. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Aspiriant Risk-Managed Equity Allocation Fund (RMEAX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RMEAX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.17 | ||
| Sortino ratioReturn per unit of downside risk | -0.16 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.37 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 2.22 | 2.78 | -0.56 |
| Martin ratioReturn relative to average drawdown | 9.80 | 12.44 | -2.64 |
Dividends
Dividend History
Aspiriant Risk-Managed Equity Allocation Fund provided a 11.09% dividend yield over the last twelve months, with an annual payout of $1.92 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.92 | $1.92 | $0.00 | $0.77 | $0.28 | $0.38 | $0.23 | $0.64 | $0.55 | $0.35 | $0.25 | $0.19 |
Dividend yield | 11.09% | 11.80% | 0.00% | 5.30% | 2.16% | 2.46% | 1.64% | 4.69% | 4.53% | 2.67% | 2.27% | 1.79% |
Monthly Dividends
The table displays the monthly dividend distributions for Aspiriant Risk-Managed Equity Allocation Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.92 | $1.92 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.77 | $0.77 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.28 | $0.28 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.38 | $0.38 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Aspiriant Risk-Managed Equity Allocation Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aspiriant Risk-Managed Equity Allocation Fund was 23.70%, occurring on Mar 20, 2020. Recovery took 180 trading sessions.
The current Aspiriant Risk-Managed Equity Allocation Fund drawdown is 0.86%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
COVID crash2020 | -23.70%Mar 2020 | 1mo 29d | 8mo 19d | 10mo 18dJan 2020 - Dec 2020 |
Bear market2022 | -21.79%Oct 2022 | 9mo 11d | 1y 2mo | 1y 11moJan 2022 - Dec 2023 |
2025 selloff2025 | -16.49%Apr 2025 | 3mo 29d | 5mo 3d | 9mo 2dDec 2024 - Sep 2025 |
2016 correction2016 | -13.86%Feb 2016 | 8mo 25d | 6mo 2d | 1y 2moMay 2015 - Aug 2016 |
2019 correction2019 | -11.04%Jan 2019 | 11mo 9d | 5mo 18d | 1y 4moJan 2018 - Jun 2019 |
Drawdown Indicators
| RMEAX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.70% | -56.78% | +33.08% |
Max Drawdown (1Y)Largest decline over 1 year | -8.41% | -9.10% | +0.69% |
Max Drawdown (3Y)Largest decline over 3 years | -16.49% | -18.90% | +2.41% |
Max Drawdown (5Y)Largest decline over 5 years | -21.79% | -25.43% | +3.64% |
Max Drawdown (10Y)Largest decline over 10 years | -23.70% | -33.92% | +10.22% |
Current DrawdownCurrent decline from peak | -0.86% | -1.80% | +0.94% |
Average DrawdownAverage peak-to-trough decline | -4.24% | -10.71% | +6.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.90% | 2.03% | -0.13% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with RMEAX
Add Aspiriant Risk-Managed Equity Allocation Fund to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with RMEAX